Drug Master Files for: PYRIDOSTIGMINE BROMIDE
✉ Email this page to a colleague
PYRIDOSTIGMINE BROMIDE Drug Master Files
DMF No. | Status | Type | Submission Date | Holder | Subject |
---|---|---|---|---|---|
10593 | A | II | 11/30/1993 | PATHEON AUSTRIA GMBH AND CO KG | PYRIDOSTIGMINE BROMIDE |
10877 | I | II | 4/11/1994 | HELSINN ADVANCED SYNTHESIS SA | PYRIDOSTIGMINE BROMIDE |
11972 | I | II | 5/10/1996 | ROCHE PRODUCTS LTD | PYRIDOSTIGMINE BROMIDE TABLETS USP 30MG |
15665 | A | II | 10/16/2001 | POLYCARBON INDUSTRIES INC DBA PCI SYNTHESIS | PYRIDOSTIGMINE BROMIDE USP |
>DMF No. | >Status | >Type | >Submission Date | >Holder | >Subject |
Drug Master File Glossary
STATUS OF DMFS
- A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
- I = Inactive
- N = Not an assigned number
- P = DMF Pending Filing Review
TYPES OF DMFs
- Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
- Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
- Type III Packaging Material
- Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
- Type V FDA Accepted Reference Information